Skip to main content
Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
177.43
+3.74 (2.15%)
At close: Jun 5, 2025, 4:00 PM
177.55
+0.12 (0.07%)
After-hours: Jun 5, 2025, 4:23 PM EDT

Ascendis Pharma External Customers Revenue
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Research and Development
255.26M 225.73M 217.85M 209.11M 213.61M 178.66M 131.50M 96.78M
Research and Development Growth
19.50% 26.34% 65.67% 116.06% 227.01% 401.03% - -
License
98.98M 122.34M 90.79M 90.51M 90.23M 66.08M 2.41M 2.48M
License Growth
9.69% 85.15% 3,668.91% 3,557.09% 3,467.93% 2,494.31% - -
Milestone
14.47M 15.57M 18.79M 18.01M 25.18M 21.98M 18.01M 19.91M
Milestone Growth
-42.54% -29.16% 4.34% -9.55% 149.69% 69.48% - -

Commercial Products Revenue
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Skytrofa
183.29M 196.95M 202.40M 202.20M 211.90M 178.90M 131.90M 97.20M
Skytrofa Growth
-13.50% 10.09% 53.45% 108.02% 222.53% 402.53% - -
Yorvipath
58.27M 13.58M - - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.